Blank SV - Search Results

1

Cross-Sectional Study of the Impact of a Natural Disaster on the Delivery of Gynecologic Oncology Care.

David-West G, Musa F, Frey MK, Boyd L, Pothuri B, Curtin JP, Blank SV. David-West G, et al. Among authors: blank sv. Disaster Med Public Health Prep. 2015 Dec;9(6):605-8. doi: 10.1017/dmp.2015.83. Epub 2015 Jul 9. Disaster Med Public Health Prep. 2015. PMID: 26155945

2

More than a name.

Blank SV, Curtin JP. Blank SV, et al. J Clin Oncol. 2007 Aug 10;25(23):3551; author reply 3557-8. doi: 10.1200/JCO.2007.12.2911. J Clin Oncol. 2007. PMID: 17687163 No abstract available.

3

Lymph node dissection in the surgical management of atypical endometrial hyperplasia.

Whyte JS, Gurney EP, Curtin JP, Blank SV. Whyte JS, et al. Among authors: blank sv. Am J Obstet Gynecol. 2010 Feb;202(2):176.e1-4. doi: 10.1016/j.ajog.2009.10.855. Epub 2009 Dec 21. Am J Obstet Gynecol. 2010. PMID: 20022313

4

Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment.

Blank SV, Christos P, Curtin JP, Goldman N, Runowicz CD, Sparano JA, Liebes L, Chen HX, Muggia FM. Blank SV, et al. Gynecol Oncol. 2010 Dec;119(3):451-6. doi: 10.1016/j.ygyno.2010.08.008. Epub 2010 Sep 15. Gynecol Oncol. 2010. PMID: 20837357 Free PMC article. Clinical Trial.

5

Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancer.

Safra T, Andreopoulou E, Levinson B, Borgato L, Pothuri B, Blank S, Tiersten A, Boyd L, Curtin J, Muggia F. Safra T, et al. Anticancer Res. 2010 Sep;30(9):3243-7. Anticancer Res. 2010. PMID: 20944093 Clinical Trial.

6

Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer.

Andreopoulou E, Chen T, Liebes L, Curtin J, Blank S, Wallach R, Hochster H, Muggia F. Andreopoulou E, et al. Cancer Chemother Pharmacol. 2011 Aug;68(2):457-63. doi: 10.1007/s00280-010-1510-y. Epub 2010 Nov 11. Cancer Chemother Pharmacol. 2011. PMID: 21069334 Clinical Trial.

7

Targeting the mTOR/4E-BP pathway in endometrial cancer.

Korets SB, Czok S, Blank SV, Curtin JP, Schneider RJ. Korets SB, et al. Among authors: blank sv. Clin Cancer Res. 2011 Dec 15;17(24):7518-28. doi: 10.1158/1078-0432.CCR-11-1664. Epub 2011 Dec 5. Clin Cancer Res. 2011. PMID: 22142830 Review.

8

A screening and prevention programme serving an ethnically diverse population of women at high risk of developing breast and/or ovarian cancer.

Smith J, Baer L, Blank S, Dilawari A, Carapetyan K, Alvear M, Utate M, Curtin J, Muggia F. Smith J, et al. Ecancermedicalscience. 2009;3:123. doi: 10.3332/ecancer.2008.123. Epub 2009 Mar 16. Ecancermedicalscience. 2009. PMID: 22275995 Free PMC article.

9

Is renal thrombotic angiopathy an emerging problem in the treatment of ovarian cancer recurrences?

Kwa M, Baumgartner R, Shavit L, Barash I, Michael J, Puzanov I, Kopolovic J, Rosengarten O, Blank S, Curtin JP, Gabizon A, Muggia F. Kwa M, et al. Oncologist. 2012;17(12):1534-40. doi: 10.1634/theoncologist.2011-0422. Epub 2012 May 23. Oncologist. 2012. PMID: 22622146 Free PMC article.

10

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer.

Verschraegen CF, Czok S, Muller CY, Boyd L, Lee SJ, Rutledge T, Blank S, Pothuri B, Eberhardt S, Muggia F. Verschraegen CF, et al. Ann Oncol. 2012 Dec;23(12):3104-3110. doi: 10.1093/annonc/mds172. Epub 2012 Jul 31. Ann Oncol. 2012. PMID: 22851407 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters